학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 110건 | 목록 1~20
Academic Journal
Lightbody ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Wu T; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Tsuji J; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Firer DT; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Agius MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Dutta AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Barr H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Kim S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Alberge JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Nersesian S; Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.; Coorens T; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Haradhvala NJ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Su NK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Boehner CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Aranha MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Rahmat M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Konishi Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Hevenor L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Towle K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Horowitz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Perry J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Davis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Walsh KA; Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Cea-Curry CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Fleming G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Vinyard ME; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Heilpern-Mallory D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; El-Khoury H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Cowan A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Ready JE; Harvard Medical School, Boston, MA, USA.; Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Marinac CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, USA.; Getz G; Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Krantz Family Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. irene_ghobrial@dfci.harvard.edu.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Academic Journal
Seismological Research Letters. 82:545-559
Academic Journal
Digital.CSIC. Repositorio Institucional del CSIC
instname
Geochemistry, Geophysics, Geosystems, Vol 13, Iss 8, Pp n/a-n/a (2012)
Academic Journal
Soupir A; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.; Ospina OE; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.; Hampton O; Aster Insights, Hudson, FL, USA.; Churchman M; Aster Insights, Hudson, FL, USA.; Radmacher M; Aster Insights, Hudson, FL, USA.; Hedges D; Aster Insights, Hudson, FL, USA.; McKean D; Aster Insights, Hudson, FL, USA.; Agius P; Aster Insights, Hudson, FL, USA.; Zeeshan S; Department of Biomedical and Health Informatics, School of Medicine, University of Missouri, Kansas City, MO, USA.; Seligson ND; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Jacksonville, FL, USA.; Pollock R; Division of Surgical Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Liebner D; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Chen JL; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Tinoco G; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Salhia B; Department of Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; McCarter M; University of Colorado School of Medicine, Aurora, CO, USA.; Wilky BA; University of Colorado School of Medicine, Aurora, CO, USA.; Miller BJ; Department of Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IO, USA.; Cavnar MJ; Department of Surgery, University of Kentucky, Lexington, KY, USA.; Groundland JS; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.; Schneider BP; Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN, 46202, USA.; Riedlinger G; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Edge SB; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Moskaluk CA; Department of Pathology, University of Virginia, Charlottesville, VA, USA.; Cardona K; Division of Surgical Oncology, Emory University, Atlanta, GA, USA.; Naqash AR; Medical Oncology/Phase 1 program, Stephenson Cancer Center, University of Oklahoma Health Sciences, Oklahoma City, OK, USA.; Gonzalez RJ; Sarcoma Department, Moffitt Cancer Center, Tampa, FL, USA.; Mullinax JE; Sarcoma Department, Moffitt Cancer Center, Tampa, FL, USA.; Joyce DM; Sarcoma Department, Moffitt Cancer Center, Tampa, FL, USA.; Binitie O; Sarcoma Department, Moffitt Cancer Center, Tampa, FL, USA.; Douglas Letson G; Sarcoma Department, Moffitt Cancer Center, Tampa, FL, USA.; Naghavi AO; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Druta M; Sarcoma Department, Moffitt Cancer Center, Tampa, FL, USA.; Reed DR; Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL, USA.; Siegel EM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.; Teer JK; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.; Fridley BL; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.; Division of Health Services and Outcomes Research, Children's Mercy, Kansas City, MO, USA.; Brohl AS; Sarcoma Department, Moffitt Cancer Center, Tampa, FL, USA. andrew.brohl@moffitt.org.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Agius, M.R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어